Chitosan coated liposomes (CCL) containing Triamcinolone Acetonide for sustained Delivery: A Potential Topical Treatment for Posterior Segment Diseases.

[1]  A. Alshamsan,et al.  The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer , 2019, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[2]  V. Rusinov,et al.  Preparation of chitosan-coated liposomes as a novel carrier system for the antiviral drug Triazavirin , 2018, Pharmaceutical development and technology.

[3]  Rinda Devi Bachu,et al.  Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases , 2018, Pharmaceutics.

[4]  Elias Fattal,et al.  Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin. , 2017, International journal of pharmaceutics.

[5]  A. Loewenstein,et al.  Drug Delivery to the Posterior Segment of the Eye. , 2017, Developments in ophthalmology.

[6]  Undurti N. Das,et al.  Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions , 2016, Archives of medical science : AMS.

[7]  Xin Wang,et al.  The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. , 2016, Colloids and surfaces. B, Biointerfaces.

[8]  B. Kuppermann,et al.  Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone. , 2016, Developments in ophthalmology.

[9]  Thomas W. Gardner,et al.  Diabetic Retinopathy and Diabetic Macular Edema. , 2016, Developments in ophthalmology.

[10]  A. Mitra,et al.  Ocular drug delivery systems: An overview. , 2013, World journal of pharmacology.

[11]  S. Honary,et al.  Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2) , 2013 .

[12]  S. Mura,et al.  Improving Oral Bioavailability and Pharmacokinetics of Liposomal Metformin by Glycerolphosphate–Chitosan Microcomplexation , 2013, AAPS PharmSciTech.

[13]  Ning Li,et al.  Low molecular weight chitosan-coated liposomes for ocular drug delivery: In vitro and in vivo studies , 2012, Drug delivery.

[14]  N. Bressler,et al.  Diabetic Macular Edema: Current and Emerging Therapies , 2012, Middle East African journal of ophthalmology.

[15]  F. Semeraro,et al.  Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration. , 2011, Current drug targets.

[16]  A. Loewenstein,et al.  Drug delivery to the posterior segment of the eye. , 2010, Developments in ophthalmology.

[17]  Shri Kant,et al.  Polymeric nanoparticulate system: a potential approach for ocular drug delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Bo Yu,et al.  Microfluidic methods for production of liposomes. , 2009, Methods in enzymology.

[19]  Ashim K. Mitra,et al.  Recent Perspectives in Ocular Drug Delivery , 2009, Pharmaceutical Research.

[20]  J. Garcia-Arumi,et al.  Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study. , 2006, Ophthalmology.